Visual Performance of Clareon PanOptix vs. a Comparable Multifocal Intraocular Lens

Inclusion Criteria

• •Stage 1: IIT Pilot
• •Willing and able to understand and sign informed consent.
• •Adult patients previously diagnosed with age-related cataracts bilaterally.
• •Previous bilateral age-related cataract removal and with bilateral implantation of the Clareon PanOptix/ Clareon PanOptix Toric (T3-T4) or Comparable Multifocal Intraocular Lens (equivalent to T3-T4) closest to 2.5-5-months after implantation and \>2 weeks post YAG (if done) that were targeted for emmetropia.
• •Best monocular corrected distance visual acuity was expected to be 0.1 logMAR (Snellen 20/25) or better in both eyes pre-operatively as determined by surgeon.
• •Normal ocular findings aside from cataract.
• •Stage 2: Comparison
• •Willing and able to understand and sign informed consent.
• •Adult patient diagnosed with age-related cataracts bilaterally.
• •Planned bilateral cataract removal by femtosecond laser-assisted phacoemulsification with bilateral implantation of the Clareon PanOptix/Clareon PanOptix Toric (T3-T4) or Comparable Multifocal Intraocular Lens (equivalent to T3-T4).
• •Best monocular corrected distance visual acuity expected to be 0.1 logMAR (Snellen 20/25) or better in both eyes postoperatively as determined by surgeon.
• •Residual astigmatism expected to be ≤ 0.50 diopters in both eyes postoperatively as determined by surgeon (after using either toric IOL or arcuate incision with laser).
• •Normal ocular findings aside from cataract.